About Cleavage stimulation factor subunit 1
Cleavage stimulation factor subunit 1 (CSTF1) is a protein
from Homo sapiens identified by UniProt accession
Q05048, 431 residues long.
MolForge cross-references it against 0 known binders and
25 disease associations.
Target properties
| Protein name | Cleavage stimulation factor subunit 1 |
| UniProt accession | Q05048 |
| Gene | CSTF1 |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (25)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.49
- mean corpuscular volume · score 0.06
- lean body mass · score 0.05
- mean corpuscular hemoglobin concentration · score 0.04
- body height · score 0.04
- mean corpuscular hemoglobin · score 0.04
- reticulocyte count · score 0.03
- appendicular lean mass · score 0.03
- mean reticulocyte volume · score 0.03
- reticulocyte measurement · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q05048-F1 | alphafold | PREDICTED | 90.43 | — |
Amino-acid sequence (431 residues)
MYRTKVGLKD RQQLYKLIIS QLLYDGYISI ANGLINEIKP QSVCAPSEQL LHLIKLGMEN DDTAVQYAIG RSDTVAPGTG IDLEFDADVQ TMSPEASEYE TCYVTSHKGP CRVATYSRDG QLIATGSADA SIKILDTERM LAKSAMPIEV MMNETAQQNM ENHPVIRTLY DHVDEVTCLA FHPTEQILAS GSRDYTLKLF DYSKPSAKRA FKYIQEAEML RSISFHPSGD FILVGTQHPT LRLYDINTFQ CFVSCNPQDQ HTDAICSVNY NSSANMYVTG SKDGCIKLWD GVSNRCITTF EKAHDGAEVC SAIFSKNSKY ILSSGKDSVA KLWEISTGRT LVRYTGAGLS GRQVHRTQAV FNHTEDYVLL PDERTISLCC WDSRTAERRN LLSLGHNNIV RCIVHSPTNP GFMTCSDDFR ARFWYRRSTT D
Explore Cleavage stimulation factor subunit 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets